Zobrazeno 1 - 10
of 417
pro vyhledávání: '"Riaz, Haris"'
In this work, we revisit the problem of semi-supervised named entity recognition (NER) focusing on extremely light supervision, consisting of a lexicon containing only 10 examples per class. We introduce ELLEN, a simple, fully modular, neuro-symbolic
Externí odkaz:
http://arxiv.org/abs/2403.17385
Best of Both Worlds: A Pliable and Generalizable Neuro-Symbolic Approach for Relation Classification
This paper introduces a novel neuro-symbolic architecture for relation classification (RC) that combines rule-based methods with contemporary deep learning techniques. This approach capitalizes on the strengths of both paradigms: the adaptability of
Externí odkaz:
http://arxiv.org/abs/2403.03305
We introduce a synthetic dataset called Sentences Involving Complex Compositional Knowledge (SICCK) and a novel analysis that investigates the performance of Natural Language Inference (NLI) models to understand compositionality in logic. We produce
Externí odkaz:
http://arxiv.org/abs/2307.05034
The new oral anti-coagulants and the phase 3 clinical trials - a systematic review of the literature
Autor:
Tahir, Faryal, Riaz, Haris, Riaz, Talha, Badshah, Maaz, Riaz, Irbaz, Hamza, Ameer, Mohiuddin, Hafsa
BACKGROUND:Anticoagulation with vitamin K antagonists such as warfarin has historically been used for the long term management of patients with thromboembolic disease. However, these agents have a slow onset of action which requires bridging therapy
Externí odkaz:
http://hdl.handle.net/10150/610256
http://arizona.openrepository.com/arizona/handle/10150/610256
http://arizona.openrepository.com/arizona/handle/10150/610256
Autor:
Riaz, Irbaz Bin, Riaz, Haris, Riaz, Talha, Rahman, Sophia, Amir, Muhammad, Badshah, Maaz, Kazi, Abdul Nafey
BACKGROUND:Hepatocellular cancer is notorious for recurrence even after curative therapy. High recurrence determines the long term prognosis of the patients. Vitamin K2 has been tested in trials for its effect on prevention of recurrence and improvin
Externí odkaz:
http://hdl.handle.net/10150/610387
http://arizona.openrepository.com/arizona/handle/10150/610387
http://arizona.openrepository.com/arizona/handle/10150/610387
Autor:
Khan, Safi U., Khan, Muhammad U., Riaz, Haris, Raggi, Paolo, Valavoor, Shahul, Khan, Muhammad Zia, Kołodziejczak, Michalina, Khan, Muhammad Shahzeb, Krupica, Troy, Alkhouli, Mohamad, Navarese, Eliano P.
Publikováno v:
In The American Journal of Cardiology 1 March 2020 125(5):727-734
Autor:
Al-Ansari Shehab, Borowski Allen, Fuad Ali, Alawadhi Omar, Riaz Haris, Sharma Vikram, Khan Nauman, Southern Brian D., Tang W.H. Wilson
Publikováno v:
Journal of Interdisciplinary Medicine, Vol 5, Iss 2, Pp 35-42 (2020)
Aim: Pirfenidone is a novel anti-fibrotic agent utilized in the treatment of idiopathic pulmonary fibrosis (IPF). It has been implicated in mitigating myocardial fibrosis and left ventricular (LV) systolic and diastolic dysfunction in animal models.
Externí odkaz:
https://doaj.org/article/28d63bae679f4d4498faf32863887b5f
Autor:
Lateef, Noman, Khan, Muhammad Shahzeb, Deo, Salil V., Yamani, Naser, Riaz, Haris, Virk, Hafeez Ul Hassan, Khan, Safi U., Hedrick, David P., Kanaan, Anmar, Reed, Grant W., Krishnaswamy, Amar, Puri, Rishi, Kapadia, Samir R., Kalra, Ankur
Publikováno v:
In The American Journal of Cardiology 1 December 2019 124(11):1757-1764
Autor:
Khan, Safi U., Riaz, Haris, Khan, Muhammad U., Zarak, Muhammad Samsoor, Khan, Muhammad Zia, Khan, Muhammad Shahzeb, Sattur, Sudhakar, Desai, Milind Y., Kaluski, Edo, Alkhouli, Mohamad
Publikováno v:
In The American Journal of Cardiology 15 November 2019 124(10):1608-1614
Autor:
Gad, Mohamed M., Saad, Anas M., Al-Husseini, Muneer J., Abushouk, Abdelrahman Ibrahim, Salahia, Sami, Rehman, Karim Abdur, Riaz, Haris, Ahmed, Haitham M.
Publikováno v:
In Cardiovascular Pathology November-December 2019 43